Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 July 2020 | Story Lacea Loader
Moderator and Panellists

As a public higher-education institution in South Africa with a responsibility to contribute to public discourse, the University of the Free State (UFS) will be presenting the 3rd UFS Thought-Leader Series in collaboration with Vrye Weekblad as part of the Vrystaat Literature Festival’s online initiative, VrySpraak-digitaal.

This year, higher-education institutions globally are placed in the challenging context of COVID-19. Aware and grounded in the reality that the world will not return to the normality of pre-COVID-19, our responsibility as scholars still remains to contribute to public discourse and to offer innovative solutions that will impact the lives of people nationally and globally in order to help them understand and adapt to a new world order.

Against this background and context, this year’s debates focus on ‘Post-COVID-19, Post-Crisis’, with Health and Modelling, Politics, Economy, and Predictions for 2021 as the sub-themes. Placed in a COVID-19 context, and in lieu of the Vrystaat Arts Festival, the series will be presented virtually in the form of one webinar per month during the period August 2020 to November 2020.

Date: 13 August 2020
Topic: Health and Modelling
Time: 11:30-13:00
RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za

Facilitator:

Max du Preez
Editor: Vrye Weekblad
Biography

Introduction and welcome:

Prof Francis Petersen
Rector and Vice-Chancellor, UFS

Panellists:

Prof Salim Abdool Karim
Director: Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Chair: South African Ministerial Advisory Committee on COVID-19
Biography

Prof Glenda Gray
President and CEO: South African Medical Research Council (SAMRC)
Biography

Prof Felicity Burt
NRF-DST South African Research Chair in vector-borne and zoonotic pathogens research
Biography

 

 

News Archive

UFS receives R3,284 million to research biosafety of genetically modified crops
2009-03-17

A testing facility at the University of the Free State (UFS), which is the only one of its kind in South Africa and a leader in its field in Africa, has received a grant of R3,284 million from the South African National Biodiversity Institute (SANBI) to do research on the biosafety of genetically modified crops in South Africa.

Prof. Chris Viljoen of the Genetically Modified Organisms (GMO) Testing Facility at the UFS says the grant forms part of a collaborative agreement between South Africa and Norway on the biosafety of GMOs.

The grant also makes provision for two M.Sc. bursaries as well as a regional biosafety workshop.

The research will focus on gene flow between genetically modified (GM) maize and non-GM maize and the potential impact thereof on the development of insect resistance.

Prof. Viljoen, who is head of Human Molecular Biology in the Department of Haematology and Cell Biology, says it is an honour to be selected to take part in the project and is groundbreaking in terms of GM maize on the environment. The project was initiated in 2009 and will run until the end of 2010.

The multi-institutional research include partners from the UFS, research groups from the University of North-West, the University of Fort Hare as well as SANBI and GenØk, the Norwegian centre for Gene Ecology. The GMO Testing Facility at the UFS was established in 2003 to perform routine GM detection for grain and food products in South Africa. The activities also include research into GM detection and biosafety of GM crops.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za
17 March 2009
 
 
Prof. Chris Viljoen of the Genetically Modified Organisms (GMO) Testing Facility at the UFS.
Photo: Supplied

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept